Elgamal AA - Search Results

1

Selective activation of the fatty acid synthesis pathway in human prostate cancer.

Swinnen JV, Vanderhoydonc F, Elgamal AA, Eelen M, Vercaeren I, Joniau S, Van Poppel H, Baert L, Goossens K, Heyns W, Verhoeven G. Swinnen JV, et al. Among authors: elgamal aa. Int J Cancer. 2000 Oct 15;88(2):176-9. doi: 10.1002/1097-0215(20001015)88:2<176::aid-ijc5>3.0.co;2-3. Int J Cancer. 2000. PMID: 11004665 Free article.

2

Morphologic and immunohistochemical changes in prostate cancer after preoperative hormonal therapy. A comparative study of radical prostatectomies.

Van de Voorde WM, Elgamal AA, Van Poppel HP, Verbeken EK, Baert LV, Lauweryns JM. Van de Voorde WM, et al. Among authors: elgamal aa. Cancer. 1994 Dec 15;74(12):3164-75. doi: 10.1002/1097-0142(19941215)74:12<3164::aid-cncr2820741216>3.0.co;2-x. Cancer. 1994. PMID: 7526970

3

del(1)(q12) in adenocarcinomas of the prostate.

Qi H, Dal Cin P, Van de Voorde W, Elgamal AA, Van Poppel H, Baert L, Van Den Berghe H. Qi H, et al. Among authors: elgamal aa. Cancer Genet Cytogenet. 1996 Mar;87(1):79-81. doi: 10.1016/0165-4608(95)00213-8. Cancer Genet Cytogenet. 1996. PMID: 8646748

4

Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation.

Elgamal AA, Ectors NL, Sunardhi-Widyaputra S, Van Poppel HP, Van Damme BJ, Baert LV. Elgamal AA, et al. J Urol. 1996 Aug;156(2 Pt 1):464-8. doi: 10.1097/00005392-199608000-00040. J Urol. 1996. PMID: 8683704 Clinical Trial.

5

Free-to-total prostate specific antigen ratio as a single test for detection of significant stage T1c prostate cancer.

Elgamal AA, Cornillie FJ, Van Poppel HP, Van de Voorde WM, McCabe R, Baert LV. Elgamal AA, et al. J Urol. 1996 Sep;156(3):1042-7; discussion 1047-9. J Urol. 1996. PMID: 8709304

6

Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens--a different view.

Elgamal AA, Van Poppel HP, Van de Voorde WM, Van Dorpe JA, Oyen RH, Baert LV. Elgamal AA, et al. J Urol. 1997 Jan;157(1):244-50. doi: 10.1016/s0022-5347(01)65337-0. J Urol. 1997. PMID: 8976263

7

Immunohistochemical localization of prostate-specific markers within the accessory male sex glands of Cowper, Littre, and Morgagni.

Elgamal AA, Van de Voorde W, Van Poppel H, Lauweryns J, Baert L. Elgamal AA, et al. Urology. 1994 Jul;44(1):84-90. doi: 10.1016/s0090-4295(94)80014-6. Urology. 1994. PMID: 7518986

8

Exophytic papillary prostatic duct adenocarcinoma with endometrioid features, occurring in prostatic urethra after TURP.

Elgamal AA, Van de Voorde W, Van Poppel H, Vandeursen H, Baert L, Lauweryns J. Elgamal AA, et al. Urology. 1994 May;43(5):737-42. doi: 10.1016/0090-4295(94)90202-x. Urology. 1994. PMID: 7513110 Review.

9

Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group.

Van Poppel H, De Ridder D, Elgamal AA, Van de Voorde W, Werbrouck P, Ackaert K, Oyen R, Pittomvils G, Baert L. Van Poppel H, et al. Among authors: elgamal aa. J Urol. 1995 Aug;154(2 Pt 1):429-34. doi: 10.1097/00005392-199508000-00027. J Urol. 1995. PMID: 7541860 Clinical Trial.

10

Re: The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population.

Elgamal AA, Baert L. Elgamal AA, et al. J Urol. 1998 Mar;159(3):994-5. doi: 10.1016/s0022-5347(01)63814-x. J Urol. 1998. PMID: 9474213 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page